Early data shows nearly 2x prolonged median survival for inoperable pancreatic cancer

Data presented at the 2017 Annual Meeting of the American Society for Radiation Oncology (ASTRO) displayed early results using the MRIdian system for the treatment of inoperable, locally advanced pancreatic cancer. MRIdian allows clinicians to see the...

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2yB9Ejv
via IFTTT